130466-38-5
|
|
- CAS号:
- 130466-38-5
- 英文名:
- Methanesulfonamide,N-[2-[(2R,12bS)-1,3,4,6,7,12b-hexahydro-2'-oxospiro[2H-benzofuro[2,3-a]quinolizine-2,4'-imidazolidin]-3'-yl]ethyl]-,hydrochloride (1:1)
- 英文别名:
- MK-467 hydrochloride;L-659066 hydrochloride;Vatinoxan hydrochloride;Methanesulfonamide,N-[2-[(2R,12bS)-1,3,4,6,7,12b-hexahydro-2'-oxospiro[2H-benzofuro[2,3-a]quinolizine-2,4'-imidazolidin]-3'-yl]ethyl]-,hydrochloride (1:1)
- 中文名:
- 130466-38-5
- 中文别名:
- 化合物 T13285
- CBNumber:
- CB63186264
- 分子式:
- C20H27ClN4O4S
- 分子量:
- 454.97
- MOL File:
- 130466-38-5.mol
|
|
|
130466-38-5化学性质
-
储存条件:
-
Store at -20°C
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to off-white
-
|
-
水溶解性:
-
Water : ≥ 133 mg/mL (292.33 mM)
-
|
130466-38-5性质、用途与生产工艺
Vatinoxan hydrochloride (MK-467hydrochloride;L-659066 hydrochloride) 是一种外周 α2 肾上腺素能受体 (α2 adrenergic receptor) 拮抗剂。
Vatinoxan alone increases cardiac index and tissue oxygen delivery and has no deleterious adverse effects. Vatinoxan attenuates or prevents dexmedetomidine’s systemic hemodynamic effects in a dose-dependent manner when given simultaneously i.v. but has no effect on the pulmonary outcome in conscious dogs. A 50:1 dose ratio (Vatinoxan:dexmedetomidine) induces the least alterations in cardiovascular function. Vatinoxan dose-dependently attenuates the bradycardia associated with dexmedetomidine, and shortens the sedative effect without altering its quality. Vatinoxan may be useful in attenuating reductions in heart rate in conscious catsadministered dexmedetomidine.
130466-38-5
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-19057A | 130466-38-5 Vatinoxan hydrochloride | 130466-38-5 | 5mg | 8500元 |
2024/01/25 | HY-19057A | Vatinoxan hydrochloride | | 1 mg | 3800元 |
130466-38-5, 130466-38-5 相关搜索:
- API
- C20H26N4O4SClH
- 化合物 T13285
- 130466-38-5
- MK-467 hydrochloride
- L-659066 hydrochloride
- Vatinoxan hydrochloride
- Methanesulfonamide,N-[2-[(2R,12bS)-1,3,4,6,7,12b-hexahydro-2'-oxospiro[2H-benzofuro[2,3-a]quinolizine-2,4'-imidazolidin]-3'-yl]ethyl]-,hydrochloride (1:1)